Amendment to Memorandum of Association of the company pursuant to increase in authorised capital of the company and for inserting new objects clause
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd has amended its Memorandum of Association following shareholder approval at an Extraordinary General Meeting held on 23 May 2025. The authorised share capital has been increased from Rs. 16 crore (1.6 crore equity shares of Rs. 10 each) to Rs. 25 crore (2.5 crore equity shares of Rs. 10 each), a rise of about 56% or Rs. 9 crore. Additionally, a new sub-clause has been added to the Objects Clause, allowing the company to venture into new business areas such as biofuels, food processing, green technologies, information technology including deep tech, logistics, e-commerce, clinical research, pharma, advisory services, and investment/management consulting. The company is broadening its operational scope well beyond its existing activities.
The authorised capital hike creates room for the company to issue fresh equity shares in the future, which could mean a potential fundraising round or stock issuance later on. The expanded objects clause signals management's intent to diversify into multiple new sectors, which could be positive for long-term growth but also raises execution risk. Existing shareholders should watch for any subsequent announcement of a rights issue, preferential allotment, or further capital-raising action.